ClinicalTrials.govpublic full text
Treatment of Rivaroxaban Versus Aspirin for Non-disabling Cerebrovascular Events
ischemic stroke, tia, rivaroxaban, aspirin, new oral anticoagulant, acute minor ischemic stroke, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 845432
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.